{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:37:44Z","timestamp":1786991864492,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"publisher","award":["281035"],"award-info":[{"award-number":["281035"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jconrel.2018.10.022","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T18:10:55Z","timestamp":1539886255000},"page":"157-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Protamine nanocapsules as carriers for oral peptide delivery"],"prefix":"10.1016","volume":"291","author":[{"given":"Lungile Nomcebo","family":"Thwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Pan","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Marigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Benetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Chenlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara V.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulay","family":"Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Dieguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi Stefania","family":"Csaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-9567","authenticated-orcid":false,"given":"Maria Jose","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.10.022_bb0005","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.biotechadv.2014.07.006","article-title":"A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules","volume":"32","author":"Choonara","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0010","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1021\/bm500169p","article-title":"Drug carriers for the delivery of therapeutic peptides","volume":"15","author":"Du","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2016.1206074","article-title":"Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes","volume":"14","author":"Thwala","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2012.02.009","article-title":"Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose","volume":"81","author":"Niu","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00914037.2014.921919","article-title":"Prerequisite characteristics of nanocarriers favoring oral insulin delivery: nanogels as an opportunity","volume":"64","author":"Mudassir","year":"2015","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13346-011-0023-5","article-title":"Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin","volume":"1","author":"Fonte","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2015.02.010","article-title":"Polymer-based nanoparticles for oral insulin delivery: revisited approaches","author":"Fonte","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2006.10.016","article-title":"Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles","volume":"334","author":"Yoncheva","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2010.02.001","article-title":"A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa","volume":"149","author":"Makhlof","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2337\/diab.37.2.246","article-title":"New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier","volume":"37","author":"Damge","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/17425247.2.5.843","article-title":"The potential of chitosan for the oral administration of peptides","volume":"2","author":"Prego","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0168-3659(90)90013-J","article-title":"Nanocapsules as carriers for oral peptide delivery","volume":"13","author":"Damg\u00e9","year":"1990","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0065","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acsnano.5b00028","article-title":"Overcoming the Diffusion Barrier of Mucus and Absorption Barrier of Epithelium by Self-Assembled Nanoparticles for Oral Delivery of Insulin","volume":"9","author":"Shan","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejpb.2015.09.019","article-title":"Protamine-based nanoparticles as new antigen delivery systems","volume":"97","author":"Gonz\u00e1lez-Aramundiz","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0075","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1021\/bc0501451","article-title":"Protamine as an efficient membrane-translocating peptide","volume":"16","author":"Reynolds","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0080","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","article-title":"Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration","volume":"32","author":"Xia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0085","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1016\/j.biomaterials.2013.06.047","article-title":"The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption","volume":"34","author":"He","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2016.05.015","article-title":"Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates","volume":"233","author":"Sheng","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0095","unstructured":"E. Pharmacopoeia, I. Units, L. The, C. Add, D. Heat, T.S.S. Dissolve, D. Prepare, D. Protamine, Protamine sulphate protamini sulfas protirelinum, TEST 85 (n.d.) 2334\u20132335."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1023\/A:1022109905487","article-title":"A less toxic heparin antagonist--low molecular weight protamine","volume":"68","author":"Liang","year":"2003","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.actbio.2015.06.035","article-title":"Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease","volume":"25","author":"Yin","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajps.2014.03.001","article-title":"Application of sialic acid\/polysialic acid in the drug delivery systems","volume":"9","author":"Zhang","year":"2014","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0115","first-page":"125","article-title":"Improving the therapeutic efficacy of peptides and proteins: A role for polysialic acids","volume":"300","author":"Gregoriadis","year":"2005"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0927-7765(02)00053-X","article-title":"Design of lipid nanoparticles for the oral deli v ery of hydrophilic macromolecules","volume":"27","author":"Garc\u00eda-Fuentes","year":"2002","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0125","series-title":"The Enhancing Effect of Sodium Glycocholate and Sodium Salicylate on Rats Gastro-intestinal Permeability to Insulin","first-page":"87","author":"Moghimipour","year":"2004"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s003960050050","article-title":"Development of positively charged colloidal drug carriers:chitosan-coated polyester nanocapsules and submicron-emulsions","volume":"275","author":"Calvo","year":"1997","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0135","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.carres.2009.04.018","article-title":"Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release","volume":"344","author":"Shu","year":"2009","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0140","doi-asserted-by":"crossref","unstructured":"A.C. Garcia-Rendueles Ar, Rodrigues JS, Garcia-Rendueles ME, Suarez-Fari\u00f1a M, Perez-Romero S, Barreiro F, Bernabeu I, Rodriguez-Garcia J, Fugazzola L, Sakai T, Liu F, Cameselle-Teijeiro J, Bravo SB, Rewiring of the apoptotic TGF-\u03b2-SMAD\/NF\u03baB pathway through an oncogenic function of p27 in human papillary thyroid cancer., Oncogene 5 (2017) 652\u2013666. doi:https:\/\/doi.org\/10.1038\/onc.2016.233. Epub 2016 Jul 25.","DOI":"10.1038\/onc.2016.233"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0145","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14227\/DT160309P21","article-title":"Simulating the proximal human gastrointestinal tract: an update","author":"Jantratid","year":"2009","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0155","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.idairyj.2006.06.015","article-title":"Medium-chain triglycerides","volume":"16","author":"Marten","year":"2006","journal-title":"Int. Dairy J."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0278-6915(99)00106-4","article-title":"Review of the toxicologic properties of medium-chain triglycerides","volume":"38","author":"Traul","year":"2000","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0165","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1002\/jps.22138","article-title":"In vivo study of a polymeric glucose-sensitive insulin delivery system using a rat model","volume":"99","author":"Taylor","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0170","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejphar.2011.09.023","article-title":"Long circulating chitosan\/PEG blended PLGA nanoparticle for tumor drug delivery","volume":"670","author":"Parveen","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0180","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2004.04.026","article-title":"Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density","volume":"98","author":"Vila","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2013.04.003","article-title":"Bile salts and their importance for drug absorption","volume":"453","author":"Holm","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2007.03.009","article-title":"Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterization","volume":"340","author":"Liu","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0195","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2005.12.015","article-title":"Chitosan\u2013PEG nanocapsules as new carriers for oral peptide delivery","volume":"111","author":"Prego","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0200","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1023\/A:1018968611962","article-title":"Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats","volume":"11","author":"A Yamamoto","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejpb.2006.01.015","article-title":"Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage","volume":"63","author":"Abdelwahed","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2004.07.030","article-title":"Transmucosal macromolecular drug delivery","volume":"101","author":"Prego","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.10.002","article-title":"The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach","volume":"243","author":"Thwala","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.10.022_bb0220","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.2042-7158.1997.tb06022.x","article-title":"Poly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue","volume":"49","author":"Damg\u00e9","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.10.022_bb0225","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejpb.2014.12.021","article-title":"In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration","volume":"97","author":"Inchaurraga","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918305935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918305935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T17:34:38Z","timestamp":1543599278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918305935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":45,"alternative-id":["S0168365918305935"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.10.022","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protamine nanocapsules as carriers for oral peptide delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}